Skip to main content
FinSpry Logo
FinSpry
AMRX logo
AMRX
(NASDAQ)
Amneal Pharmaceuticals, Inc.
$12.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Amneal Pharmaceuticals (AMRX) Stock Price & Financial Analysis

Amneal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.28 - $12.67
52-Week High$15.42
52-Week Low$6.69
Open$12.39
Volume1.35M
Average Volume (3M)1.35M
Market Cap4.05B
Shares Outstanding324.81M
P/E Ratio (TTM)57.29
Price to Sales (P/S)1.37
EV/EBITDA10.85
Revenue (TTM)3.02B
Net Income (TTM)72.06M
Free Cash Flow (TTM)228.63M
EPS (TTM)$0.22
Profit Margin2.39%
Operating Margin13.18%
50-Day MA$13.50
200-Day MA$11.09
52-Week Change54.44%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Amneal Pharmaceuticals

What is the current stock price for AMRX?

As of the latest trading session, AMRX stock trades at $12.48. The 52-week range is $6.69–$15.42, with a day range of $12.28–$12.67.

What is the P/E ratio for AMRX?

Amneal Pharmaceuticals's trailing P/E ratio is 57.3, meaning investors pay $57.3 for every $1 of annual earnings. Amneal Pharmaceuticals operates in the Healthcare sector.

Does AMRX pay dividends?

Amneal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AMRX?

Based on 1 analyst, the consensus for AMRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AMRX?

Amneal Pharmaceuticals's market capitalization is $4.05B, classifying it as a mid-cap company. Amneal Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.